{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:21:10Z","timestamp":1790263270128,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K19722"],"award-info":[{"award-number":["16K19722"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08651"],"award-info":[{"award-number":["20K08651"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaip.2020.08.048","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T07:32:19Z","timestamp":1599377539000},"page":"1166-1176.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Improved Fc\u03b5RI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria"],"prefix":"10.1016","volume":"9","author":[{"given":"Yoshiko","family":"Oda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Washio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Nishigori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.08.048_bib1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2222.1974.tb01384.x","article-title":"Serum and cell bound IgE in chronic urticaria","volume":"4","author":"Greaves","year":"1974","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib3","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI108405","article-title":"Defective histamine release in chronic urticaria","volume":"57","author":"Kern","year":"1976","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2020.08.048_bib4","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/jid.2008.55","article-title":"Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies","volume":"128","author":"Eckman","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2020.08.048_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2006.09.035","article-title":"Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria","volume":"119","author":"Vonakis","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.08.048_bib6","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/all.13215","article-title":"Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria","volume":"72","author":"Rauber","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib7","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.jaip.2019.05.020","article-title":"Low responsiveness of basophils via FcepsilonRI reflects disease activity in chronic spontaneous urticaria","volume":"7","author":"Oda","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.08.048_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaip.2019.08.004","article-title":"Association of basophil parameters with disease severity and duration in chronic spontaneous urticaria (CSU)","volume":"8","author":"Huang","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.08.048_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1398-9995.1962.tb02937.x","article-title":"Basophilic leucopenia in different forms of urticaria","volume":"17","author":"Rorsman","year":"1962","journal-title":"Acta Allergol"},{"key":"10.1016\/j.jaip.2020.08.048_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2222.2003.01589.x","article-title":"Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity","volume":"33","author":"Grattan","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/all.12578","article-title":"Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria","volume":"70","author":"Oliver","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bjd.12991","article-title":"Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin","volume":"171","author":"Kay","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2020.08.048_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaci.2015.06.004","article-title":"Altered expression of chemoattractant receptor-homologous molecule expressed on T(H)2 cells on blood basophils and eosinophils in patients with chronic spontaneous urticaria","volume":"137","author":"Oliver","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.08.048_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2018.03.007","article-title":"Recent advancement in the mechanism of basophil activation","volume":"91","author":"Nakashima","year":"2018","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2020.08.048_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003495-200161020-00008","volume":"61","author":"Easthope","year":"2001","journal-title":"Omalizumab. Drugs"},{"key":"10.1016\/j.jaip.2020.08.048_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1189\/jlb.70.2.207","article-title":"IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils","volume":"70","author":"MacGlashan","year":"2001","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaip.2020.08.048_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/all.13083","article-title":"Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria","volume":"72","author":"Kaplan","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/jdv.12693","article-title":"Omalizumab may not inhibit mast cell and basophil activation in\u00a0vitro","volume":"29","author":"Gericke","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2020.08.048_bib19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jid.2016.11.025","article-title":"Effect of omalizumab on blood basophil counts in patients with chronic idiopathic\/spontaneous urticaria","volume":"137","author":"Saini","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2020.08.048_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.alit.2019.02.002","article-title":"Basophil count is a sensitive marker for clinical progression in a chronic spontaneous urticaria patient treated with omalizumab","volume":"68","author":"Kishimoto","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2020.08.048_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cea.13066","article-title":"Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients","volume":"48","author":"J\u00f6rg","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaip.2015.11.025","article-title":"Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria","volume":"4","author":"Palacios","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.08.048_bib23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2340\/00015555-2654","article-title":"Basophil Fc\u03b5RI expression in chronic spontaneous urticaria: a potential immunological predictor of response to omalizumab therapy","volume":"97","author":"Deza","year":"2017","journal-title":"Acta Dermato Venereologica"},{"key":"10.1016\/j.jaip.2020.08.048_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2016.07.047","article-title":"Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria","volume":"139","author":"Gericke","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.08.048_bib25","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jaci.2018.02.021","article-title":"Basophil Fc\u03b5RI expression is linked to time to omalizumab response in chronic spontaneous urticaria","volume":"141","author":"Deza","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.08.048_bib26","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaip.2017.10.030","article-title":"Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria","volume":"6","author":"Straesser","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.08.048_bib27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/all.13345","article-title":"The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change","volume":"73","author":"Ertas","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/jdv.12831","article-title":"Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels","volume":"30","author":"Altrichter","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2020.08.048_bib29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2013.12.1076","article-title":"Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control","volume":"133","author":"Weller","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.08.048_bib30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/1346-8138.14502","article-title":"Impact of chronic urticaria on quality of life and work in Japan: results of a real-world study","volume":"45","author":"Itakura","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2020.08.048_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.alit.2018.11.003","article-title":"The Urticaria Control Test and Urticaria Activity Score correlate with quality of life in adult Japanese patients with chronic spontaneous urticaria","volume":"68","author":"Nakatani","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2020.08.048_bib32","first-page":"143","article-title":"Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues","volume":"18","author":"De Week","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2020.08.048_bib33","series-title":"Omalizumab clinical pharmacologic review","year":"2013"},{"key":"10.1016\/j.jaip.2020.08.048_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cea.13566","article-title":"Response of Fc\u03b5RI-bearing leucocytes to omalizumab in chronic spontaneous urticaria","volume":"50","author":"Alizadeh Aghdam","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.08.048_bib35","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.jaci.2016.12.965","article-title":"Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab","volume":"139","author":"MacGlashan","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.08.048_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.cr.7290301","article-title":"Identification of CD13, CD107a, and CD164 as novel basophilactivation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation","volume":"15","author":"Hennersdorf","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.jaip.2020.08.048_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jim.2011.09.003","article-title":"Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils","volume":"375","author":"Ebo","year":"2012","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaip.2020.08.048_bib38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.2010.05918.x","article-title":"New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation","volume":"1217","author":"Siracusa","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jaip.2020.08.048_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.alit.2017.09.003","article-title":"Chronic spontaneous urticaria and the extrinsic coagulation system","volume":"67","author":"Yanase","year":"2018","journal-title":"Allergol Int"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820308801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820308801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:52:04Z","timestamp":1778853124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820308801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2213219820308801"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.08.048","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Fc\u03b5RI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}